News Jianmin Pharmaceutical Group Co.,Ltd.

Equities

600976

CNE000001HB7

End-of-day quote Shanghai S.E. Other stock markets 06:00:00 2024-04-28 pm EDT			5-day change	1st Jan Change
56.35 ^CNY	+1.28%		-0.74%	-13.64%

Apr. 19	Jianmin Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Apr. 16	Jianmin Pharma Gets Nod to Market Asthma Drug	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Jianmin Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 19	CI
Jianmin Pharma Gets Nod to Market Asthma Drug	Apr. 16	MT
Jianmin Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 15	CI
Jianmin Pharmaceutical’s Drugs Remain Covered by China’s National Medical Insurance	Dec. 15	MT
Jianmin Pharmaceutical Earmarks 132 Million Yuan to Expand China Factory; Shares Jump 8%	Nov. 17	MT
Jianmin Pharma Gets Nod to Market Drug For Children's Acute Bronchitis	23-10-23	MT
Jianmin Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-20	CI
Jianmin Pharma Receives Nod to Market Oral Solution For Epilepsy Patients	23-10-17	MT
Jianmin Pharmaceutical Group Co.,Ltd.(XSSC:600976) added to S&P Global BMI Index	23-09-18	CI
Jianmin Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-08	CI
Jianmin Pharmaceutical Group Co.,Ltd. completed the acquisition of 6.13% stake in HeraMED Limited from Hua Li Pharmaceutical Group Co.,Ltd.	23-07-24	CI
Jianmin Pharma Gets Nod to Market Atomoxetine Hydrochloride Oral Solution; Shares Drop 3%	23-05-25	MT
Jianmin Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-17	CI
Jianmin Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-14	CI
Jianmin Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-14	CI
Jianmin Pharma's Liver, Stomach Disease Drug Included in China’s Medical Insurance Catalog	23-01-19	MT
Jianmin Pharma to Buy 4.5% of Australia’s Hera Med for 8.4 Million Yuan	22-12-28	MT
Jianmin Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-21	CI
Jianmin Pharmaceutical Group Co.,Ltd. intends to acquire Zhejiang Huafang Medical Care Co., Ltd from Holley Group Company Limited, Zhejiang Holley Investment Management Co., Ltd. and Suzhou Yuanyi Zhiyuan Equity Investment Partnership (Limited Partnership) for CNY 15.2 million.	22-08-16	CI
Jianmin Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22-07-19	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Jianmin Pharmaceutical Group Co.,Ltd.

Equities

600976

CNE000001HB7

Summary

Filters